Physician profile
Edwin Melendez
NPI 1447274436
$3,126.15
in general payments reported to CMS, 2019-2025
8 companies · $680 in 2025
The $680 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $781 · 2020: $119 · 2021: $338 · 2022: $691 · 2023: $150 · 2024: $366 · 2025: $680.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,196.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,449.25 | 2019-2024 | Tapestry |
| Polynovo North America LLC | $885.18 | 2022-2025 | Novosorb Btm |
| Smith+Nephew, INC. | $291.12 | 2019-2022 | |
| Biocircuit Technologies INC | $187.85 | 2025 | Nerve Tape |
| Penumbra, INC. | $140.89 | 2025 | Indigo System |
| Amgen INC. | $124.95 | 2024 | Evenity |
| Integra Lifesciences Corporation | $26.68 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Axogen | $20.23 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edwin Melendez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.